IBD (IBD) Stock Price & Analysis
IBD (IBD) fell 0.23% to USD 23.45 as of September 8, 2026 at 21:28 UTC, according to Nexqual real-time market data.
IBD last closed at USD 23.51; the session ranged USD 23.45–23.56 on volume of 156,307 shares. Market capitalization is —, with a 52-week range of USD 22.94–24.78 (PCX). Source: Nexqual, September 8, 2026 at 21:28 UTC.
Key Statistics (as of September 8, 2026 at 21:28 UTC)
| Price | USD 23.45 |
|---|---|
| Change | ▼ 0.23% (down) |
| Previous Close | USD 23.51 |
| Open | USD 23.54 |
| Day Range | USD 23.45 – 23.56 |
| 52-Week Range | USD 22.94 – 24.78 |
| Volume | 156,307 shares |
| Market Cap | — |
| Exchange | PCX |
Technical Analysis (IBD)
Nexqual's technical model rates IBD "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 21:28 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 33.82 (neutral) |
| vs SMA50 | Below (USD 23.65) |
| MACD | -0.05 (negative) |
Financial Health Score (IBD)
Nexqual rates IBD's overall financial health "Mixed" across five dimensions, as of September 8, 2026 at 21:28 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ISMD | Inspire Small/Mid Cap ETF | USD 48.68 | ▼ 0.14% |
| BLES | Inspire Global Hope ETF | USD 49.66 | ▼ 0.65% |
| BIBL | Inspire 100 ETF | USD 55.42 | ▲ 0.66% |
| WWJD | Inspire International ETF | USD 40.97 | ▼ 0.41% |
| RISN | Inspire Capital Appreciation ET | USD 30.82 | ▼ 1% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 21:28 UTC. This page is informational and not investment advice.